ECSP045408A - Composición farmacéutica que comprende arsenito para el tratamiento de malignidad - Google Patents

Composición farmacéutica que comprende arsenito para el tratamiento de malignidad

Info

Publication number
ECSP045408A
ECSP045408A EC2004005408A ECSP045408A ECSP045408A EC SP045408 A ECSP045408 A EC SP045408A EC 2004005408 A EC2004005408 A EC 2004005408A EC SP045408 A ECSP045408 A EC SP045408A EC SP045408 A ECSP045408 A EC SP045408A
Authority
EC
Ecuador
Prior art keywords
tumor
treatment
pharmaceutical composition
arsenite
malignity
Prior art date
Application number
EC2004005408A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29244880&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP045408(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of ECSP045408A publication Critical patent/ECSP045408A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La invención se refiere a una composición farmacéutica para el tratamiento de una malignidad sólida escogida del grupo consistente en tumor de colon, tumor gástrico, tumor mamario, tumor ovárico, tumor prostático y tumor renal, dicha composición comprende una sal de meta-arsenito (AsO2) y un auxiliar farmacéuticamente aceptable. Esta invención también se relaciona a su uso y a su método de tratamiento.
EC2004005408A 2002-04-10 2004-11-04 Composición farmacéutica que comprende arsenito para el tratamiento de malignidad ECSP045408A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2002/000231 WO2003086424A1 (en) 2002-04-10 2002-04-10 Pharmaceutical composition comprising arsenite for the treatment of malignancy

Publications (1)

Publication Number Publication Date
ECSP045408A true ECSP045408A (es) 2006-03-01

Family

ID=29244880

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005408A ECSP045408A (es) 2002-04-10 2004-11-04 Composición farmacéutica que comprende arsenito para el tratamiento de malignidad

Country Status (25)

Country Link
US (1) US20050106262A1 (es)
EP (2) EP1496918B1 (es)
JP (1) JP2005525397A (es)
CN (1) CN1298332C (es)
AP (1) AP2004003167A0 (es)
AU (2) AU2002253713B2 (es)
BG (1) BG66356B1 (es)
BR (1) BR0215689A (es)
CA (1) CA2481602C (es)
CY (1) CY1114422T1 (es)
DK (2) DK2042182T3 (es)
EC (1) ECSP045408A (es)
ES (2) ES2944907T3 (es)
FI (1) FI1496918T3 (es)
HU (1) HU230851B1 (es)
IL (2) IL164470A0 (es)
LT (1) LT1496918T (es)
MX (1) MXPA04009898A (es)
NO (1) NO335317B1 (es)
NZ (1) NZ536452A (es)
PT (2) PT1496918T (es)
RO (1) RO123269B1 (es)
TN (1) TNSN04198A1 (es)
UA (1) UA80426C2 (es)
WO (1) WO2003086424A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006024488A2 (en) * 2004-08-30 2006-03-09 Interstitial Therapeutics Medical stent provided with inhibitors of atp synthesis
EP1721615A1 (en) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8945505B2 (en) 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
US20090246291A1 (en) * 2008-03-27 2009-10-01 Angelika Burger Method and compositions for treatment of cancer
US20100249210A1 (en) * 2008-09-30 2010-09-30 Michael Bastiani Methods and compositions related to dlk-1 and the p38 mapk pathway in nerve regeneration
CN102060722B (zh) * 2009-05-01 2014-06-11 常州高新技术产业开发区三维工业技术研究所有限公司 一种含砷化合物及其制备方法和用途
PL2475362T3 (pl) * 2009-09-10 2019-09-30 Kominox, Inc. Terapia celowana w nowotworowe komórki macierzyste i raka lekoopornego
RU2012108439A (ru) * 2009-09-18 2013-10-27 Коминокс, Инк. Способы лечения опухолей головного мозга
CN101695501B (zh) * 2009-10-10 2013-08-14 广汉恒宇新材料有限公司 一种纳米尺寸亚砷酸的壳聚糖包载体及其制造方法
CA3094115A1 (en) 2018-03-22 2019-09-26 Komipharm International Australia Pty Ltd Pharmaceutical composition comprising meta arsenite and method of manufacture

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804928B1 (en) * 1994-02-18 2004-10-20 Tamara Vasilievna Vorobieva Agent having an immunomodulating effect and reducing disturbed functioning of the tissue cell propagation regulating system
EP1391206B1 (en) * 1997-10-15 2008-07-02 Polarx Biopharmaceuticals, Inc. Pharmaceutical compositions comprising arsenic trioxide for the treatment of non-Hodgkin's lymphoma
CN1119152C (zh) * 1998-08-02 2003-08-27 哈尔滨医科大学第一临床医学院 治疗消化系统肿瘤注射液及其应用

Also Published As

Publication number Publication date
PT1496918T (pt) 2023-05-25
BG66356B1 (bg) 2013-09-30
CY1114422T1 (el) 2016-08-31
DK2042182T3 (da) 2013-08-26
DK1496918T3 (da) 2023-05-15
AU2008255139B2 (en) 2013-10-03
CN1625407A (zh) 2005-06-08
HUP0500199A2 (en) 2007-02-28
PT2042182E (pt) 2013-08-28
ES2944907T3 (es) 2023-06-27
EP1496918A1 (en) 2005-01-19
AP2004003167A0 (en) 2004-12-31
AU2002253713B2 (en) 2008-09-18
BR0215689A (pt) 2005-02-01
EP1496918B1 (en) 2023-02-08
NZ536452A (en) 2007-06-29
JP2005525397A (ja) 2005-08-25
IL164470A (en) 2010-12-30
CN1298332C (zh) 2007-02-07
BG108932A (en) 2005-11-30
TNSN04198A1 (en) 2007-03-12
WO2003086424A1 (en) 2003-10-23
RO123269B1 (ro) 2011-05-30
UA80426C2 (en) 2007-09-25
CA2481602C (en) 2011-06-21
ES2425418T3 (es) 2013-10-15
US20050106262A1 (en) 2005-05-19
AU2002253713A1 (en) 2003-10-27
EP2042182A1 (en) 2009-04-01
CA2481602A1 (en) 2003-10-23
LT1496918T (lt) 2023-05-25
NO20044573L (no) 2004-10-22
NO335317B1 (no) 2014-11-10
MXPA04009898A (es) 2005-06-20
FI1496918T3 (fi) 2023-05-11
IL164470A0 (en) 2005-12-18
AU2008255139A1 (en) 2009-01-08
HUP0500199A3 (en) 2008-03-28
EP2042182B1 (en) 2013-05-22
HU230851B1 (en) 2018-09-28

Similar Documents

Publication Publication Date Title
CL2007001624A1 (es) Uso de un anticuerpo que se une a dll4 para el tratamiento de tumor, cancer o trastorno de proliferacion celular.
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
SA521430055B1 (ar) عمليات ومركبات لتحضير مدهور مستقبل إستروجين انتقائي
DK1378240T3 (da) Farmaceutiske præparater omfattende arsentrioxid til behandling af multipelt myelom
CL2009001492A1 (es) Compuestos derivados de pirrolotriazina, inhibidores de cinasa; composicion farmaceutica; y uso para tratar una enfermedad proliferativa tal como cancer, psoriasis y artritis reumatoide (divisional de la sol. 3313-04).
UY27943A1 (es) Composiciones y mctodos para tratar el crncer usando inmunoconjugados de anticuerpo para cd44 citotnxicos y agentes quimioterapcuticos
WO2006044826A3 (en) Thiophens and their use as anti-tumor agents
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
BR0015490A (pt) Combinações oncolìticas para o tratamento de câncer
GEAP202516674A (en) Indazole macrocycles and their use
TW200731991A (en) Lipophilic di(anticancer drug) compounds, compositions and related methods
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
ATE502025T1 (de) Arylcarboxamide und ihre verwendung als antitumormittel
PL361597A1 (en) Pharmaceutical compound, application of selenium or its compounds as well as the method for reducing breast or ovary cancer hazard
EA200600404A1 (ru) Пероральные препаративные формы кладрибина
AP2004003167A0 (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
TNSN07453A1 (en) Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases
WO2005085188A3 (en) Compounds and methods for anti-tumor therapy
BR0214799B1 (pt) instalação flutuante para tratamento de hidrocarbonetos.
PT1427420E (pt) Utilizacao de uma combinacao compreendendo 4- piridilmetilftalazinas para o tratamento do cancro
ATE471708T1 (de) 2-heterosubstituierte 3-aryl-4-h-1-benzopyran-4- one als neue therapeutika bei brustkrebs
DK1521752T3 (da) Makrocykliske forbindelser til behandling af cancer
ECSP044991A (es) Uso de 4-piridilmetil-ftalazinas para el tratamiento de cancer
UA67597A (en) Method for treating prostate cancer